COMPARISON OF EFFICACY AND SAFETY SILODOSIN 8 MG ONCE DAILY AND SILODOSIN 4 MG TWICE DAILY IN BPH PATIENTS WITH LUTS

COMPARISON OF EFFICACY AND SAFETY SILODOSIN 8 MG ONCE DAILY AND SILODOSIN 4 MG TWICE DAILY IN BPH PATIENTS WITH LUTS

Objective: This study was aimed to compare the efficacy and side effect of silodosin 8mg once daily and silodosin 4mg twice daily in BPH-LUTS patients after 4 and 12 weeks. Material & Methods: Single blind randomized controlled trials in 60 male patients aged ≥45 years with BPH-LUTS from July 20...

Full description

Bibliographic Details
Main Authors:	Ramzie Nendra Diansyah, Johan Renaldo, Wahjoe Djatisoesanto, Lukman Hakim
Format:	Article
Language:	English
Published:	IKATAN AHLI UROLOGI INDONESIA 2019-01-01
Series:	Jurnal Urologi Indonesia
Subjects:	Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms International Prostate Symptom Score Qmax Ejaculation Disorder
Online Access:	http://juri.urologi.or.id/juri/article/view/552

Similar Items

Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity
by: Abdullah Gul, et al.
Published: (2020-12-01)

Comparison of transurethral incision of the prostate and silodosin in patients having benign prostatic obstruction in terms of retrograde ejaculation
by: Basri Cakiroglu, et al.
Published: (2017-03-01)

Focus on Silodosin: Pros and Cons of Uroselectivity
by: Califano G, et al.
Published: (2020-12-01)

Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study
by: Ferdinando Fusco, et al.
Published: (2018-03-01)

Efficacy and safety of silodosin in the treatment of lower urinary tract symptoms in elderly men taking antihypertensive medications
by: Woo Suk Choi, et al.
Published: (2017-09-01)

Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH
by: Xinyang Liao, et al.
Published: (2020-04-01)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
by: Claus G Roehrborn, et al.
Published: (2008-09-01)

To Assess the Quality of Life in Patients with Benign Prostate Hyperplasia (BPH) Based on Urinary Symptoms
by: Divmehar Kaur, et al.
Published: (2020-03-01)

International prostate symptom score - IPSS - AUA as discriminat scale in 400 male patients with lower urinary tract symptoms (LUTS)
by: Paulo Rodrigues, et al.
Published: (2004-04-01)

ANALYSIS OF DIFFERENCES DEGREE OF SEVERITY AND QUALITY OF LIFE OF BPH DIABETES WITH BPH NON-DIABETES PATIENTS
by: Prayoga Triyadi Kurnia Putra, et al.
Published: (2019-07-01)

Role of once-daily tadalafil in men with concomitant erectile dysfunction and symptomatic benign prostatic hyperplasia: A prospective randomized placebo-controlled study
by: Sunder Goyal, et al.
Published: (2015-01-01)

The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
by: Konstantinos Stamatiou
Published: (2018-03-01)

SUCCESS RATES OF TAMSULOSIN AND DUTASTERIDE AS MEDICAL THERAPY BASED ON IPSS IN SYMPTOMATIC BPH PATIENTS IN ARIFIN ACHMAD HOSPITAL PEKANBARU RIAU
by: Zuhirman Zamzami
Published: (2018-07-01)

DIFFERENCES IN THE EFFECTIVENESS OF SELECTIVE ALPHA BLOCKER THERAPY COMBINED WITH 5-ALPHA REDUCTASE INHIBITOR ON IPSS VALUE OF BPH LUTS PATIENTS
by: Septa Surya Wahyudi, et al.
Published: (2020-07-01)

The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
by: Young Won Kim, et al.
Published: (2015-09-01)

Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post- Marketing Surveillance Study
by: Ji Eon Won, et al.
Published: (2018-05-01)

Impacts of medical treatments for lower urinary tract symptoms suggestive to benign prostatic hyperplasia on male sexual functions
by: Shih-Tsung Huang
Published: (2016-03-01)

Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH
by: Xing-Huan Wang, et al.
Published: (2015-01-01)

Comparative analysis of clinical effectiveness of α1-adrenoblockers doxazosin, tamsulosin and silodosin in males with chronic non-inflammatory prostatitis
by: A O Lobkarev, et al.
Published: (2018-12-01)

Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia
by: Ankur Garg, et al.
Published: (2020-01-01)

New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes
by: Enrico Checcucci, et al.
Published: (2021-11-01)

Alfuzosin and Its Effect on Ejaculatory Dysfunction: A Systematic Review
by: Haywood E. L. Yeung, et al.
Published: (2021-04-01)

Clinical implications of using questionnaires in elderly men with urinary disorders
by: V. A. Dudarev, et al.
Published: (2020-12-01)

RELATIONSHIP OF PERIURETHRAL FIBROTIC IN BPH PATIENT WITH LUTS AND URINARY RETENTION
by: Zamroni Zamroni, et al.
Published: (2017-07-01)

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
by: IQBAL SINGH, et al.
Published: (2015-06-01)

HoLEP does not affect the overall sexual function of BPH patients: a prospective study
by: Sung Han Kim, et al.
Published: (2014-12-01)

Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population
by: Yogesh Taneja, et al.
Published: (2017-12-01)

Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy
by: Umut Karaca, et al.
Published: (2021-03-01)

Use and ease of self-administered International Prostate Symptoms Score (IPSS) and Visual Prostate Symptoms Score (VPSS) questionnaires for the assessment of lower urinary tract symptoms in Nigerian men
by: O.O. Abiola, et al.
Published: (2016-06-01)

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement
by: Simon Allen, et al.
Published: (2016-12-01)

MALE GENITAL TUBERCULOSIS AS A REASON FOR REPRODUCTIVE DISORDER
by: A. V. Osadchiy, et al.
Published: (2015-09-01)

Symptomatic multiple prostatic calculi: A case report and literature review
by: Tomy Nurtamin, et al.
Published: (2021-09-01)

Prostate embolization: patient selection, clinical management and results
by: Shamar Young, et al.
Published: (2019-01-01)

Quick Prostate Test (QPT): Motion for a tool for the active contribution of the general pratictioner to the diagnosis and follow up of benign prostatic hyperplasia
by: Giuseppe Albino, et al.
Published: (2014-12-01)

The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study
by: Mahmoud S. El-Adawy, et al.
Published: (2019-12-01)

Effect of Silodosin and Deflazacort Combination in Reducing Symptoms Related to Indwelling Ureteric Stent: A Randomised, Double-Blind Tria
by: Debabrata Kumar Sabat, et al.
Published: (2020-02-01)

An observational study to monitor the efficacy and tolerability of levofloxacin 500 mg once daily for treatment of chronic bacterial prostatitis in Saudi Arabia
by: Amr Ismail El Meliegy, et al.
Published: (2015-01-01)

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity
by: Nevzat Can Sener, et al.
Published: (2013-07-01)

The LEST technique: Treatment of prostatic obstruction preserving antegrade ejaculation in patients with benign prostatic hyperplasia
by: Rosario Leonardi
Published: (2019-03-01)

Predictors of the international prostate symptoms scores for patients with lower urinary tract symptoms: A descriptive cross-sectional study
by: Christian Kofi Gyasi-Sarpong, et al.
Published: (2018-01-01)